These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9194150)

  • 1. Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.
    Walden J; von Wegerer J; Winter U; Berger M; Grunze H
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):697-706. PubMed ID: 9194150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review.
    Grunze H; Langosch J; Schirrmacher K; Bingmann D; Von Wegerer J; Walden J
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov; 25(8):1555-70. PubMed ID: 11642654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the serotonin-1A agonists buspirone and ipsapirone on field potentials in the hippocampus slice: comparison with carbamzepine and verapamil.
    Walden J; von Wegerer J; Roed I; Berger M
    Eur Neuropsychopharmacol; 1995 Mar; 5(1):57-61. PubMed ID: 7613104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
    Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
    Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23.
    Ma Y; Sachdeva K; Liu J; Ford M; Yang D; Khan IA; Chichester CO; Yan B
    Drug Metab Dispos; 2004 Nov; 32(11):1317-24. PubMed ID: 15282211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
    Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
    Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Densitometric analysis of kawain in kava-kava root extracts.
    Janeczko Z; Krzek J; Pilewski N; Walusiak D
    Acta Pol Pharm; 2001; 58(6):463-8. PubMed ID: 12197620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociceptive actions of kava components in mice.
    Jamieson DD; Duffield PH
    Clin Exp Pharmacol Physiol; 1990 Jul; 17(7):495-507. PubMed ID: 2401103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites.
    Gleitz J; Friese J; Beile A; Ameri A; Peters T
    Eur J Pharmacol; 1996 Nov; 315(1):89-97. PubMed ID: 8960869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A calcium antagonistic effect of the new antiepileptic drug lamotrigine.
    von Wegerer J; Hesslinger B; Berger M; Walden J
    Eur Neuropsychopharmacol; 1997 May; 7(2):77-81. PubMed ID: 9169293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents.
    Backhauss C; Krieglstein J
    Eur J Pharmacol; 1992 May; 215(2-3):265-9. PubMed ID: 1396990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats.
    Baum SS; Hill R; Rommelspacher H
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1105-20. PubMed ID: 9829291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.
    Smith KK; Dharmaratne HR; Feltenstein MW; Broom SL; Roach JT; Nanayakkara NP; Khan IA; Sufka KJ
    Psychopharmacology (Berl); 2001 Apr; 155(1):86-90. PubMed ID: 11374340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs.
    Grunze H; Walden J
    Magnes Res; 1997 Jun; 10(2):119-26. PubMed ID: 9368232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kavain, dihydrokavain, and dihydromethysticin non-competitively inhibit the specific binding of [3H]-batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated Na+ channels.
    Friese J; Gleitz J
    Planta Med; 1998 Jun; 64(5):458-9. PubMed ID: 9690349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+/-)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex.
    Gleitz J; Beile A; Peters T
    Neuropharmacology; 1995 Sep; 34(9):1133-8. PubMed ID: 8532183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
    Uebelhack R; Franke L; Schewe HJ
    Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
    Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
    Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.